Investment Rating - The report maintains a strong buy rating for the company [4][6]. Core Insights - The company's revenue growth has turned positive, with a 0.01% year-on-year increase in 2025, showing a significant recovery from a -0.51% decline in the previous quarters [3][4]. - Retail wealth management has regained its core advantages, with a 21.39% growth in wealth management revenue and a retail AUM exceeding 17 trillion, reflecting a 14.44% increase [2][4]. - The net interest margin remained stable at 1.87% for 2025, with a slight decline of 11 basis points from the beginning of the year, but is expected to narrow further in 2026 due to ongoing optimization of funding costs [2][4]. Summary by Sections Performance - In 2025, the company's total revenue reached 337.532 billion, with a year-on-year growth of 0.01% [5][14]. - The net profit attributable to shareholders was 150.181 billion, reflecting a 1.21% increase year-on-year [5][14]. Non-Interest Income - The company reported a 4.39% growth in non-interest income, with significant contributions from wealth management [2][16]. Interest Margin and Assets - The net interest margin for 2025 was 1.87%, stable compared to previous quarters, while the yield on interest-earning assets decreased to 2.89% [2][13]. Asset Quality - The non-performing loan ratio stood at 0.94% at the end of 2025, with a slight increase in the annual generation rate to 1.03% [4][14]. Capital and Shareholders - The company maintains a strong capital position with a capital adequacy ratio of 18.24% [14][30]. Profit Forecast - Revenue growth is projected to be 5.3%, 6.8%, and 7.7% for 2026, 2027, and 2028 respectively, with net profit growth expected at 5.2%, 6.5%, and 7.6% [4][5].

Core Viewpoint - The performance report of China Merchants Bank (CMB) for the year 2025 highlights concerns regarding retail loan quality and net interest margin, with a slight increase in non-performing loans (NPLs) in retail lending despite a rebound in net interest margin in the fourth quarter [1][2]. Group 1: Retail Loan Quality - The NPL ratio for small and micro loans increased significantly from 0.79% to 1.22%, while the personal housing loan NPL ratio rose from 0.48% to 0.51%. Conversely, the consumer loan NPL ratio decreased from 1.04% to 1.02% [2]. - CMB's Vice President and Chief Risk Officer noted that the overall risk in retail credit is still on the rise, with pressures on asset quality due to the ongoing adjustment in the real estate market and employment conditions [2]. - The bank plans to optimize its business structure by tightening loan approval standards, especially for consumer loans, and dynamically adjusting standards for small and micro loans to mitigate risks [2]. Group 2: Credit Card Performance - Despite a decline in the credit card industry, CMB saw an increase in the number of circulating cards and cardholders, but experienced a 7.62% year-on-year drop in credit card transaction volume to 4.08 trillion yuan [3]. - The bank's strategy focuses on maintaining stable asset quality, even at the cost of reduced revenue contribution from credit cards [3]. Group 3: Net Interest Margin - CMB's net interest margin for 2025 was reported at 1.87%, a decrease of 0.11 percentage points year-on-year, although a rebound was observed in the fourth quarter [4]. - The quarterly breakdown shows net interest margins of 1.91%, 1.86%, and 1.83% for the first three quarters, with a recovery to 1.86% in the fourth quarter [4]. - The bank has made efforts to improve the asset-liability structure by increasing the proportion of higher-yielding assets and reducing lower-yielding assets [4]. Group 4: Future Outlook on Net Interest Margin - The bank anticipates that net interest margin will continue to narrow in 2026, but at a slower rate compared to the previous year, influenced by external factors and the timing of loan repricing [5]. - CMB aims to achieve a smaller reduction in net interest margin and stabilize it in the second half of 2026, provided there are no significant policy changes [6].

Investment Rating - The report maintains a "Recommend" rating for China Merchants Bank (600036) with a target price of 53.87 CNY / 66.90 HKD, based on a projected price-to-book (PB) ratio of 1.15 for 2026 [4][8]. Core Insights - The bank's revenue growth has turned positive, with a reported revenue of 337.53 billion CNY for 2025, reflecting a slight increase of 0.01% year-on-year. The net profit attributable to shareholders reached 150.18 billion CNY, up 1.21% year-on-year [2][8]. - The bank's asset quality remains stable, with a non-performing loan (NPL) ratio holding steady at 0.94% and a provision coverage ratio decreasing to 392% [2][8]. - Wealth management business has shown significant growth, with a 31.3% year-on-year increase in revenue for this segment, contributing to a 16.3% growth in total income for the fourth quarter of 2025 [8]. Financial Performance Summary - Total revenue for 2025 is projected at 337.53 billion CNY, with expected growth rates of 2.87%, 5.69%, and 4.59% for 2026, 2027, and 2028 respectively [9]. - Net profit attributable to shareholders is forecasted to be 150.18 billion CNY in 2025, with growth rates of 1.93%, 4.91%, and 5.65% for the subsequent years [9]. - The bank's earnings per share (EPS) is expected to increase from 5.89 CNY in 2025 to 6.66 CNY by 2028 [11]. Asset Quality and Risk Indicators - The NPL ratio is projected to slightly decrease to 0.91% in 2026 and further to 0.86% in 2028, indicating a stable asset quality outlook [12]. - The provision coverage ratio is expected to decline to 311.04% by 2028, reflecting a strong risk mitigation capacity [12]. - The bank's overall risk indicators remain stable, with a focus on maintaining a healthy balance between asset growth and risk management [8][12].

Core Viewpoint - Bank of America Securities maintains its earnings forecast for China Merchants Bank (03968, 600036.SH) for 2026 and 2027, while lowering the target prices to HKD 49.8 and RMB 43.28 from HKD 50.52 and RMB 45.49 respectively, reiterating a "underperform" rating and showing a preference for state-owned banks with higher dividend yields [1] Group 1 - The target price for China Merchants Bank's Hong Kong stock has been adjusted to HKD 49.8 [1] - The target price for China Merchants Bank's A-shares has been adjusted to RMB 43.28 [1] - The stock has not received any ratings from investment banks in the past 90 days, indicating low attention from analysts [1] Group 2 - China Merchants Bank has a market capitalization of HKD 225.046 billion, ranking 8th in the banking industry [1] - The bank's performance metrics are summarized in a table, although specific figures are not provided in the text [1]

Group 1 - The core viewpoint of the report is that Bank of America Securities maintains its profit forecasts for China Merchants Bank (03968, 600036.SH) for 2026 and 2027, while lowering the target prices to HKD 49.8 and RMB 43.28 from HKD 50.52 and RMB 45.49 respectively, reiterating a "underperform" rating and favoring state-owned banks with higher dividend yields [1][5] Group 2 - The net profit before preferred dividends for China Merchants Bank last year was RMB 150.2 billion, representing a year-on-year increase of 1.2%, in line with previous guidance [1][5] - The pre-provision profit decreased by 1.6% year-on-year [1][5] - The return on equity (ROE) fell by 1.0 percentage points to 13.4% year-on-year [1][5] - The Common Equity Tier 1 (CET1) capital ratio decreased by 97 basis points to 14.16% year-on-year [1][5] - The dividend payout ratio remained at 35.3%, with the annual dividend per share increasing by 0.8% to RMB 2.016 [1][5] - The estimated dividend yields for the H-shares and A-shares of China Merchants Bank are 4.7% and 5.1% respectively [1][5]

该行称，招商银行去年扣除优先股股息前净利润为1,502亿元人民币，同比增长1.2%，符合先前指引。 拨备前利润同比下跌1.6%。股本回报率(ROE)同比下跌1.0个百分点至13.4%。普通股权一级资本比率 (CET1)同比下跌97个基点至14.16%。另外，派息比率维持35.3%，每股股息同比上升0.8%至2.016元人 民币，估算招行H股及招行A股的股息收益率分别为4.7%及5.1%。 智通财经APP获悉，美银证券发布研报称，该行大致维持招商银行(03968,600036.SH)2026及2027年盈利 预测不变，目标价由50.52港元及45.49元人民币，分别下调至49.8港元及43.28元人民币。重申"跑输大 市"评级，并偏好股息收益率较高的国有银行。 ...

Core Viewpoint - The core viewpoint of the article emphasizes that the true competitive advantage of China Merchants Bank (CMB) lies in its internalization of a customer-centric philosophy into its corporate culture, distinguishing it from many other banks in mainland China [1] Group 1: Corporate Culture - CMB's chairman, Miao Jianmin, highlighted that many within the bank previously believed that retail banking and financial technology were the main competitive advantages, but the real strength is the customer-centric culture [1] - The bank's culture is reflected in the behavior of its employees, who are noted to rarely leave work on time, indicating a commitment to customer service [1] - An example of this culture is illustrated by the rapid completion of communication materials for analysts and investors, which took only two days after the 2025 annual performance announcement [1]

平安证券研报指出，招商银行25年全年实现营业收入3375亿元，同比持平24年末，实现归母净利润1502 亿元，同比正增1.2%。盈利增速持续修复，财富管理业务修复明显。公司营收和资产质量受到宏观环 境的扰动较大，但长期角度下的竞争优势依然稳固，营收能力绝对水平仍位于同业领先地位，长期价值 依然可期。考虑到招商银行息差边际企稳资产质量稳健，小幅上调公司的盈利预测，并新增28年盈利预 测，维持"强烈推荐"评级。 ...

Group 1 - The report highlights that Chaoyun Group has maintained high dividends for six consecutive years, with revenue and profit both showing year-on-year growth, indicating a sustainable growth outlook for its product matrix [4][5] - In 2025, Chaoyun Group achieved a revenue of 1.988 billion RMB, a year-on-year increase of 9.24%, and a net profit of 224 million RMB, up 9.98% year-on-year, with a comprehensive gross margin of 52.61% [4][5] - The company’s home care products performed well, with revenue from this segment reaching 1.715 billion RMB, a year-on-year increase of 5.0%, while the pet business saw a significant growth of 74.3% [5][6] Group 2 - Jianmin Group's revenue for 2025 was 3.370 billion RMB, a decrease of 3.85% year-on-year, but the fourth quarter showed a strong recovery with an 82.69% increase in net profit [10][11] - The pharmaceutical industrial segment of Jianmin Group reported a revenue of 2.025 billion RMB, a year-on-year increase of 15.91%, driven by strong sales of prescription and OTC products [11][12] - The company is focusing on brand development and innovation, with key products showing significant sales growth, indicating a strong recovery in its core business [11][12] Group 3 - The report on Yimeng Biotech indicates that the B7H3 ADC drug has shown excellent efficacy in treating metastatic castration-resistant prostate cancer (mCRPC), with promising clinical trial results [13][14] - The drug has received fast track designation from the FDA, highlighting its potential in the market [14][15] - The clinical study included 146 patients, showing a median radiographic progression-free survival of 11.3 months, indicating strong therapeutic potential [15][16] Group 4 - Pop Mart reported a revenue of 37.12 billion RMB in 2025, a year-on-year increase of 184.7%, with adjusted net profit rising by 284.5% [18][19] - The company has seen a significant increase in online sales, which accounted for 44.3% of total revenue, reflecting a shift in consumer purchasing behavior [21][22] - The number of IPs generating over 2 billion RMB in revenue has increased, with the "Star People" IP showing a remarkable growth of 1602% [25][26] Group 5 - CIMC Vehicles reported a revenue of 20.18 billion RMB in 2025, a decrease of 3.9% year-on-year, but with a strong performance in the Chinese market, where semi-trailer sales increased by 15% [28][29] - The company anticipates a recovery in the North American market in 2026, with significant order rebounds indicating a potential turnaround [29][30] - The report emphasizes the company's strategic positioning in the global market, particularly in the southern regions, which are expected to drive future growth [28][29] Group 6 - Power Development reported a revenue of 5.293 billion RMB in 2025, a decrease of 6.4% year-on-year, but maintained a high profit margin despite market challenges [32][33] - The company achieved a high dividend payout ratio of 123%, reflecting its commitment to returning value to shareholders [33][34] - The report outlines ongoing projects that are expected to enhance production capacity significantly in the coming years, indicating strong growth potential [34][35] Group 7 - Bluestar Technology is recognized as a leader in adsorption separation materials, with significant growth driven by innovation and market demand in various sectors [37][38] - The company is positioned to benefit from the growing market for small nucleic acid drugs, with projections indicating substantial growth in this area [38][39] - The report forecasts revenues of 2.733 billion RMB for 2025, with a strong growth trajectory expected in subsequent years [39]

Core Viewpoint - Bank of America Securities reports that China Merchants Bank's net profit before preferred stock dividends for the previous year was 150.2 billion yuan, reflecting a year-on-year growth of 1.2%, in line with prior guidance [1] Financial Performance - Return on equity (ROE) decreased by 1.0 percentage points year-on-year to 13.4% [1] - Common Equity Tier 1 (CET1) capital ratio fell by 97 basis points year-on-year to 14.16% [1] - The dividend payout ratio remained at 35.3%, with the annual dividend per share increasing by 0.8% to 2.016 yuan [1] Dividend Yield - Estimated dividend yields for the bank's H-shares and A-shares are 4.7% and 5.1%, respectively [1] Price Target Adjustments - The bank maintains its earnings forecasts for 2026 and 2027, while lowering the target price for H-shares from 50.52 HKD to 49.8 HKD and for A-shares from 45.49 CNY to 43.28 CNY [1] - The rating is reiterated as "underperform," with a preference for state-owned banks with higher dividend yields [1]